Thumbnail Image
Item

Expression of stemness genes in primary breast cancer tissues: The role of SOX2 as a prognostic marker for detection of early recurrence

Finicelli, M
; 
Benedetti, G
; 
Squillaro, T
; 
Pistilli, B
; 
Marcellusi, A
; 
Mariani, P
; 
Santinelli, A
; 
Latini, L
; 
Galderisi, U
; 
Giordano, A
Citations
Altmetric:
Genre
Journal Article
Date
2014-01-01
Advisor
Committee member
Group
Department
Subject
Breast Cancer
 Gene expression
 Recurrence
 SOX2
 Stemness genes
Permanent link to this record
http://hdl.handle.net/20.500.12613/5336
Collections
Faculty/Researcher Works
Show all metadata
Files
Thumbnail Image
Expression of stemness genes in primary breast cancer tissues the role of SOX2 as a prognostic marker for detection of early.pdf
Adobe PDF, 1.66 MB
Research Projects
Organizational Units
Journal Issue
DOI
10.18632/oncotarget.1936
Abstract
The events leading to breast cancer (BC) progression or recurrence are not completely understood and new prognostic markers aiming at identifying high riskpatients and to develop suitable therapy are highly demanded. Experimental evidences found in cancer cells a deregulated expression of some genes involved in governance of stem cell properties and demonstrated a relationship between stemness genes overexpression and poorly differentiated BC subtypes. In the present study 140 primary invasive BC specimens were collected. The expression profiles of 13 genes belonging to the OCT3/SOX2/NANOG/KLF4 core circuitry by RT-PCR were analyzed and any correlation between their expression and the BC clinic-pathological features (CPfs) and prognosis was investigated. In our cohort (117 samples), NANOG, GDF3 and SOX2 significantly correlated with grade 2, Nodes negative status and higher KI67 proliferation index, respectively (p=0.019, p=0.029, p= 0.035). According to multivariate analysis, SOX2 expression resulted independently associated with increased risk of recurrence (HR= 2,99; p= p=0,004) as well as Nodes status (HR=2,44; p=0,009) and T-size >1 (HR=1,77; p=0,035). Our study provides further proof of the suitable use of stemness genes in BC management. Interestingly, a prognostic role of SOX2, which seems to be a suitable marker of early recurrence irrespective of other clinicopathological features.
Description
Citation
Citation to related work
Impact Journals, LLC
Has part
Oncotarget
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
Embedded videos